Insulet | Resultat Før Skatt



Pre Tax Profit Endring Dato
Abbott USD 2.03B 90M 2024-12
Align Technology USD 140.78M 25.15M 2024-12
AtriCure USD -15302000 7.77M 2024-12
Avanos Medical USD -420500000 443.3M 2024-12
Baxter International USD -289000000 594M 2024-12
Becton, Dickinson and Co. USD 306M 1.01B 2024-12
Boston Scientific USD 1.16B 82M 2024-12
Cardinal Health USD 511M 87M 2024-12
Cooper Companies USD 168.6M 61.6M 2024-10
Dexcom USD 231.9M 5.1M 2024-12
Edwards Lifesciences USD 395.2M 42.7M 2024-12
Eli Lilly USD 5.54B 3.83B 2024-12
Globus Medical USD 120.72M 23.97M 2024-12
ICU Medical USD 48.78M 3.55M 2024-09
Insulet USD 111.3M 26.4M 2024-12
Integra LifeSciences USD -18237000 98.27M 2024-12
J&J USD 5.42B 1.86B 2024-12
Masimo USD -361700000 410.4M 2024-12
Medtronic USD 1.54B 455M 2025-01
Merit Medical Systems USD 149.99M 83.98M 2024-12
Roche Holding CHF 1.78B 2.33B 2024-12
Solventum Corp 367M 59M 2024-09
Stryker USD 1.64B 376M 2024-12
Tandem Diabetes Care USD -91870000 69.26M 2024-12
Teleflex USD -126760000 316.46M 2024-12
West Pharmaceutical Services USD 168.1M 4.3M 2024-12
Zimmer Biomet Holdings USD 289M 104.4M 2024-12



Insulet Resultat Før Skatt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.